The other major risk factor is a weakened immune system, especially HIV infection, which raises the chance that exposure to active TB becomes latent infection and then active disease. Close contact explains whether bacilli reach your lungs; immune competence explains whether they take hold. A person at risk for a tuberculosis (TB) infection when near a person with active TB also faces risk from infectiousness of the source case, duration and ventilation of the shared space, and host factors such as age, diabetes, and silicosis.
How Inhaled Bacilli Establish Infection
TB transmission begins with droplet nuclei, not droplets. When a person with pulmonary TB coughs, sings, or speaks, they expel particles of 1 to 5 micrometers that can stay airborne for hours and bypass the nose's defenses. A single cough can generate thousands of these nuclei, though only a minority carry viable bacilli.
Once inhaled, the organisms reach the alveoli, where alveolar macrophages engulf them. In most immunocompetent people, macrophages and T cells wall the bacilli into granulomas, producing latent TB infection (LTBI). Roughly 5 to 10 percent of infected people progress to active disease over their lifetime, and about half of that progression occurs within the first two years after infection (CDC). The immune system does not eliminate the bacteria; it contains them.
This is why immune status matters as much as proximity. A person with intact cell-mediated immunity can share a room with a coughing patient and still contain the infection. A person whose T-cell response is blunted cannot reliably hold the granuloma together, and containment fails.
Quantified Context: Exposure, Infectiousness, and Immunity
Risk is a product of three variables, and each carries numbers clinicians use. The first is source infectiousness. Patients with cavitary pulmonary disease and positive sputum smears are far more contagious than those with smear-negative disease. Laryngeal TB is especially efficient at generating aerosols.
The second is shared environment. Studies of household contacts show infection risk rises with cumulative exposure hours and falls with ventilation and ultraviolet germicidal irradiation. A crowded, unventilated room concentrates droplet nuclei; outdoor air dilutes them by orders of magnitude within minutes.
The third is host immunity. HIV is the strongest single amplifier of TB risk. People with HIV are roughly 15 to 22 times more likely to develop active TB than people without HIV (WHO). Among people with latent infection, HIV coinfection raises lifetime progression risk from about 10 percent to roughly 10 percent per year without antiretroviral therapy.
| Risk Factor | Mechanism | Relative Risk Context |
|---|---|---|
| HIV infection | Depletes CD4 T cells needed for granuloma control | 15-22x higher active TB risk (WHO) |
| Recent infection (within 2 years) | Bacilli still replicating before immune containment matures | Roughly half of lifetime progression occurs in this window |
| Diabetes mellitus | Impaired macrophage function and cellular immunity | 2-3x higher risk in several cohort analyses |
| Silicosis | Silica damages alveolar macrophages | Markedly elevated, especially in mining and construction |
| Tobacco smoking | Impaired ciliary clearance and local immunity | 1.5-2x higher risk in pooled analyses |
| Malnutrition | Protein-energy deficits blunt T-cell responses | Substantially elevated in low-resource settings |
| Immunosuppressive drugs (e.g., TNF inhibitors) | Block cytokine pathways that maintain granulomas | Reactivation risk rises, prompting screening before therapy |
Edge Cases That Change the Calculation
Several situations break the simple "close contact equals risk" rule. Extrapulmonary TB, such as TB of the spine or lymph nodes, is generally not contagious unless there is a draining lesion or concurrent lung involvement. A person caring for someone with TB meningitis faces little transmission risk from that site alone.
Children under 5 years old are a special case in the opposite direction. They rarely transmit TB because their coughs carry fewer bacilli, but they progress to active disease far more often once infected. Young children with LTBI warrant preventive treatment promptly rather than watchful waiting.
A counterintuitive professional caveat: a negative chest X-ray and a negative tuberculin skin test do not exclude recent infection. It takes 2 to 8 weeks after exposure for a skin test to convert. Screening too early can miss an infection that is already underway.
Health care workers represent another edge case. Their exposure is repeated and often unrecognized, which is why occupational screening programs exist. Risk accrues from cumulative low-dose exposures, not just one dramatic contact.
Misconceptions About Who Gets Infected
The most common misconception is that any contact guarantees infection. In reality, most exposed immunocompetent adults do not become infected, and most who do never develop active disease. Transmission probability per exposure is probabilistic, not deterministic.
Another misconception conflates latent infection with active disease. People with LTBI have no symptoms, do not feel ill, and cannot transmit TB to others. Only active pulmonary or laryngeal disease is contagious. This distinction drives screening strategy: find and treat LTBI before it reactivates.
A third misconception is that TB is historical. Globally, WHO estimates roughly 10 million new TB cases annually, and about a quarter of the world's population has latent infection. In the United States, cases occur in people born abroad, in congregate settings, and in communities with limited health care access.
A fourth is that vaccination ends risk. The bacille Calmette-Guérin (BCG) vaccine reduces severe childhood TB but does not reliably prevent adult pulmonary infection, and it can cause false-positive skin tests.
Practical Actions for Exposed People
If you learn you were near someone with active TB, act on concrete thresholds rather than waiting for symptoms.
Confirm the source case is actually infectious: ask whether it was pulmonary or laryngeal TB with a positive sputum smear, and whether the person has been on effective treatment for at least 2 weeks. Get tested if you are a close contact: a tuberculin skin test or interferon-gamma release assay is the standard first step. Repeat testing 8 to 10 weeks after the last exposure if the first test is negative, because early testing can miss conversion. Seek prompt evaluation for a cough lasting more than 2 to 3 weeks, night sweats, unexplained weight loss, fever, or coughing blood. Tell your clinician about HIV status, diabetes, immunosuppressive medications, or prior TB treatment, because these change the management threshold. If you have LTBI and a condition that suppresses immunity, ask about preventive treatment; regimens vary in duration and should be selected by a clinician.
Red-flag warnings that warrant urgent care:
Coughing blood, or coughing that persists beyond 3 weeks with fever or weight loss. Known HIV infection plus any TB exposure, since progression risk is highest. Symptoms in a child under 5 with a household TB contact. A draining skin lesion or open wound in someone with extrapulmonary TB.
Limits of What Screening and Risk Models Can Tell You
Screening tests have real limits. Interferon-gamma release assays and tuberculin skin tests detect immune sensitization, not live bacteria, so they cannot distinguish recent infection from old infection or predict who will progress. A positive result in a BCG-vaccinated person can be a false positive or a true positive, and interpretation depends on the assay and the person's history.
Risk models also cannot fully capture individual exposure. Two people in the same room may inhale vastly different numbers of droplet nuclei based on proximity, airflow, and duration. Public health contact investigations use concentric-circle interviewing to estimate exposure, but they remain estimates.
The most important limit is this: a negative test after known exposure does not mean risk is zero. It means the immune response has not yet become detectable, or that the exposure was insufficient. Repeat testing and symptom monitoring are what close the gap.
For anyone with TB exposure concerns, this article is general educational information and not a diagnosis, treatment plan, or screening order. It does not promise any outcome. Consult a qualified local clinician or public health department for testing and personalized guidance, and seek emergency services for severe symptoms such as difficulty breathing or coughing large amounts of blood.